- Home
- ADMA vs SLGN Comparison
ADMA vs SLGN Comparison
Compare ADMA & SLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- SLGN
- Stock Information
- Founded
- ADMA 2004
- SLGN 1987
- Country
- ADMA United States
- SLGN United States
- Employees
- ADMA N/A
- SLGN N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- SLGN Containers/Packaging
- Sector
- ADMA Health Care
- SLGN Industrials
- Exchange
- ADMA Nasdaq
- SLGN Nasdaq
- Market Cap
- ADMA 5.1B
- SLGN 4.8B
- IPO Year
- ADMA N/A
- SLGN 1997
- Fundamental
- Price
- ADMA $16.11
- SLGN $43.98
- Analyst Decision
- ADMA Strong Buy
- SLGN Strong Buy
- Analyst Count
- ADMA 3
- SLGN 9
- Target Price
- ADMA $27.67
- SLGN $62.22
- AVG Volume (30 Days)
- ADMA 2.9M
- SLGN 1.0M
- Earning Date
- ADMA 11-06-2025
- SLGN 10-29-2025
- Dividend Yield
- ADMA N/A
- SLGN 1.82%
- EPS Growth
- ADMA 469.09
- SLGN N/A
- EPS
- ADMA 0.85
- SLGN 2.81
- Revenue
- ADMA $474,174,000.00
- SLGN $6,162,113,000.00
- Revenue This Year
- ADMA $21.08
- SLGN $11.89
- Revenue Next Year
- ADMA $25.98
- SLGN $2.79
- P/E Ratio
- ADMA $19.06
- SLGN $15.67
- Revenue Growth
- ADMA 43.58
- SLGN 5.49
- 52 Week Low
- ADMA $13.50
- SLGN $43.76
- 52 Week High
- ADMA $25.67
- SLGN $58.14
- Technical
- Relative Strength Index (RSI)
- ADMA 37.77
- SLGN 32.64
- Support Level
- ADMA $15.74
- SLGN $43.76
- Resistance Level
- ADMA $17.17
- SLGN $45.49
- Average True Range (ATR)
- ADMA 0.52
- SLGN 0.70
- MACD
- ADMA -0.09
- SLGN 0.04
- Stochastic Oscillator
- ADMA 18.81
- SLGN 6.21
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About SLGN Silgan Holdings Inc.
Silgan Holdings manufactures about half of the metal food containers in North America. Its major customers include Campbell Soup, Nestle, and Del Monte. Silgan's other business segments include plastic dispensers and containers for personal and healthcare products and a closures business that manufactures metal and plastic lids and caps.